Uncategorized

NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results

– Fourth Quarter Revenue of $74.6 Million –

– 2008 Revenue of $250.1 Million –

– Provides 2009 Guidance –

Fourth Quarter and Full Year 2008 Highlights:

– Fourth quarter total revenue of $74.6 million; up 58.9% from the fourth quarter 2007

– Full year 2008 total revenue of $250.1 million; up 62.1% from the full year 2007

– Osteocel revenue for the second half 2008 of $10 million; exceeds prior guidance of $9 million

– Gross margin of 82.0% for the fourth quarter and 82.3% for the full year

– GAAP earnings per share was $0.10 for the fourth quarter and loss per share was $(0.77) for the full year

– Full year 2008 earnings per share of $0.10 excluding in-process research and development costs and other adjustments; exceeds prior guidance of $0.07 – $0.09

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button